Current status of treatment of primary hepatocellular carcinoma in the elderly population
10.3969/j.issn.1001-5256.2018.06.039
- VernacularTitle:老年肝细胞癌患者的治疗现状
- Author:
Yongjie HUANG
1
;
Dequan WU
;
Junhui YUAN
Author Information
1. 哈尔滨医科大学附属第二医院
- Keywords:
carcinoma;
hepatocellular;
therapy;
aged;
review
- From:
Journal of Clinical Hepatology
2018;34(6):1313-1317
- CountryChina
- Language:Chinese
-
Abstract:
With the global aging, the incidence rate of HCC in the elderly population is gradually increasing , and thus it has become a global health issue.With reference to relevant literature, this article analyzes the clinical features of elderly HCC patients and reviews the current status of therapies and clinical outcomes .The review of clinical outcomes is mainly based on the comparison of therapeutic outcome between elderly and non -elderly HCC patients in many countries and regions in the world .This article points out that elderly HCC patients have their own clinical features, and since elderly HCC patients often have other diseases , such as diabetes, renal failure, and lung and cardiovascular diseases, there is an increase in the risk of treatment, but they often have positive treatment outcomes .With the deepening of research and the improvement of various treatment methods , the therapeutic outcome of elderly HCC patients will also be improved .Therefore,positive attitude and strategies should be adopted in the clinical treatment of elderly HCC patients .
